DIA会员及用户请点击登录

登录

忘记用户 ID? or 忘记密码?

Not a Member?

创建账户并加入。

Hilton Lac-Leamy

2026 年 10 月 26 日 7:30 上午 - 2026 年 10 月 27 日 4:00 下午

3 Boulevard du Casino, Gatineau, QC J8Y 6X4, Canada

Canada Annual Meeting

The Canada Annual Meeting offers three tracks, Regulatory, Clinical, Safety and Pharmacovigilance!

亮点与特色

What is happening at Canada Annual Meeting



Need Approval in Order to Attend?

Download and fill out our Justification Letter to demonstrate to your supervisor why this is a must-attend event.



  • Convene regulators, industry, academia, patients, and technology leaders to explore Canada's evolving role in advancing global regulatory science and healthcare product development.
  • Foster collaboration between Health Canada, international regulatory agencies, industry, and other key stakeholders to accelerate innovation, regulatory convergence, and patient access.
  • Deliver practical, implementation-focused education across regulatory affairs, clinical development, and pharmacovigilance that equips participants to navigate evolving policies, digital transformation, and emerging technologies.
  • Showcase innovative approaches to AI, real-world evidence, decentralized clinical trials, precision medicine, and modern pharmacovigilance that are transforming product development and regulatory decision-making.
  • Create opportunities for meaningful peer-to-peer engagement through plenary sessions, interactive concurrent sessions, networking events, and direct dialogue with Health Canada leadership.

  • Hear directly from Health Canada leadership through exclusive agency updates, regulatory insights, and the Health Canada Town Hall.
  • Gain practical strategies, not just policy updates, for implementing AI, regulatory modernization initiatives, ICH guidance, inspection readiness, and digital transformation.
  • Stay ahead of Canada's evolving regulatory landscape with timely discussions on reliance, real-world evidence, structured submissions, precision medicine, and pharmacovigilance.
  • Learn from cross-functional experts representing regulatory affairs, clinical development, pharmacovigilance, quality, academia, and technology.
  • Build valuable connections with regulators, industry leaders, researchers, patient representatives, and solution providers from across Canada's life sciences ecosystem.


Three Educational Tracks: Regulatory, Clinical, Safety and Pharmacovigilance


Track A: Regulatory

This track delves into Canada's evolving regulatory landscape, providing a platform for exchanging insights, practical use cases, and emerging best practices. Sessions will focus on both current and upcoming regulatory requirements, key policy developments, regulatory convergence and innovative strategies that are influencing life sciences R&D in Canada. Sessions will aim to equip attendees with actionable knowledge to effectively navigate regulatory expectations and enhance the quality of submissions in an increasingly complex environment.

Track B: Clinical

This track explores the evolving landscape of clinical research development and operations in Canada, offering a platform to exchange insights, real-world applications, and emerging best practices. Sessions will aim to equip attendees with practical knowledge to successfully design and execute clinical programs in an increasingly complex and fast-paced environment.

Track C: Safety and Pharmacovigilance

This track brings together industry, health authorities, and other stakeholders to share best practices and advance product safety across all product types. Sessions will explore regulatory insights, cross-functional interfaces, and emerging trends and technologies.

获得信息并保持参与

不要错失任何机会——请加入我们的邮件列表,了解DIA的观点和事件。